Asian Phytoceuticals PCL
SET:APCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
TH |
|
U
|
Urban Lithium Inc
KOSDAQ:073570
|
KR |
|
Gazprom Gazoraspredeleniye Rostov-Na-Donu PAO
MOEX:RTGZ
|
RU |
|
W
|
WK Kellogg Co
NYSE:KLG
|
US |
|
Alpha Capital Acquisition Co
NASDAQ:ASPC
|
KY |
|
E
|
Eureka Acquisition Corp
NASDAQ:EURK
|
CN |
|
Brenntag SE
XETRA:BNR
|
DE |
|
SAXA Holdings Inc
TSE:6675
|
JP |
|
Denyo Co Ltd
TSE:6517
|
JP |
|
Sreeleathers Ltd
NSE:SREEL
|
IN |
|
J
|
Jiangsu Financial Leasing Co Ltd
SSE:600901
|
CN |
|
R
|
Revitalist Lifestyle and Wellness Ltd
OTC:RVLWF
|
US |
|
Ting Sin Co Ltd
TWSE:2358
|
TW |
|
P
|
Pihlajalinna Oyj
OMXH:PIHLIS
|
FI |
Balance Sheet
Balance Sheet Decomposition
Asian Phytoceuticals PCL
Asian Phytoceuticals PCL
Balance Sheet
Asian Phytoceuticals PCL
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
24
|
45
|
86
|
84
|
54
|
84
|
303
|
377
|
214
|
222
|
244
|
182
|
160
|
100
|
99
|
82
|
126
|
62
|
103
|
|
| Cash |
0
|
0
|
3
|
1
|
43
|
59
|
118
|
153
|
133
|
222
|
244
|
182
|
160
|
100
|
99
|
82
|
126
|
62
|
103
|
|
| Cash Equivalents |
24
|
44
|
83
|
83
|
11
|
25
|
185
|
224
|
81
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
225
|
195
|
0
|
0
|
195
|
315
|
271
|
313
|
320
|
72
|
68
|
97
|
126
|
289
|
257
|
|
| Total Receivables |
7
|
14
|
19
|
19
|
12
|
8
|
13
|
15
|
12
|
4
|
4
|
5
|
1
|
5
|
3
|
4
|
4
|
5
|
3
|
|
| Accounts Receivables |
6
|
13
|
19
|
9
|
12
|
7
|
11
|
13
|
5
|
4
|
4
|
5
|
1
|
4
|
3
|
4
|
4
|
5
|
3
|
|
| Other Receivables |
1
|
1
|
0
|
10
|
1
|
1
|
2
|
2
|
7
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
40
|
42
|
49
|
49
|
42
|
41
|
40
|
52
|
48
|
51
|
53
|
67
|
62
|
62
|
60
|
53
|
44
|
57
|
69
|
|
| Other Current Assets |
1
|
1
|
2
|
2
|
2
|
3
|
2
|
2
|
4
|
2
|
2
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
6
|
|
| Total Current Assets |
72
|
102
|
156
|
154
|
335
|
330
|
358
|
447
|
473
|
596
|
574
|
569
|
545
|
241
|
231
|
238
|
301
|
416
|
438
|
|
| PP&E Net |
55
|
60
|
60
|
60
|
71
|
88
|
92
|
106
|
147
|
107
|
94
|
84
|
71
|
113
|
91
|
64
|
82
|
66
|
48
|
|
| PP&E Gross |
55
|
60
|
60
|
60
|
71
|
88
|
92
|
106
|
147
|
107
|
94
|
84
|
71
|
113
|
91
|
64
|
82
|
66
|
48
|
|
| Accumulated Depreciation |
42
|
41
|
48
|
50
|
53
|
60
|
63
|
69
|
84
|
78
|
88
|
100
|
114
|
125
|
125
|
131
|
194
|
208
|
218
|
|
| Intangible Assets |
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Investments |
7
|
7
|
7
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
2
|
3
|
4
|
332
|
347
|
365
|
304
|
136
|
124
|
|
| Other Long-Term Assets |
3
|
3
|
3
|
3
|
4
|
6
|
6
|
8
|
7
|
8
|
8
|
9
|
10
|
10
|
11
|
13
|
17
|
17
|
17
|
|
| Total Assets |
138
N/A
|
172
+25%
|
226
+32%
|
218
-4%
|
410
+89%
|
426
+4%
|
457
+7%
|
563
+23%
|
629
+12%
|
711
+13%
|
679
-5%
|
666
-2%
|
630
-5%
|
697
+11%
|
681
-2%
|
680
0%
|
705
+4%
|
636
-10%
|
628
-1%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
1
|
1
|
3
|
2
|
2
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
1
|
1
|
10
|
8
|
11
|
16
|
17
|
21
|
24
|
23
|
19
|
18
|
19
|
16
|
13
|
14
|
16
|
16
|
15
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
19
|
12
|
13
|
13
|
12
|
|
| Other Current Liabilities |
12
|
28
|
40
|
18
|
19
|
22
|
27
|
18
|
23
|
26
|
18
|
17
|
12
|
14
|
14
|
18
|
16
|
9
|
13
|
|
| Total Current Liabilities |
16
|
30
|
53
|
29
|
33
|
41
|
46
|
40
|
49
|
50
|
38
|
37
|
31
|
49
|
48
|
45
|
46
|
39
|
40
|
|
| Long-Term Debt |
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
32
|
15
|
2
|
22
|
11
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
5
|
5
|
7
|
7
|
12
|
12
|
13
|
15
|
19
|
21
|
22
|
23
|
24
|
27
|
25
|
|
| Total Liabilities |
16
N/A
|
30
+89%
|
53
+77%
|
32
-40%
|
39
+22%
|
46
+20%
|
53
+15%
|
48
-10%
|
61
+28%
|
62
+2%
|
50
-19%
|
52
+2%
|
51
-2%
|
101
+100%
|
86
-16%
|
72
-16%
|
95
+32%
|
79
-17%
|
71
-11%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
93
|
93
|
93
|
93
|
200
|
200
|
200
|
272
|
275
|
300
|
300
|
300
|
300
|
300
|
300
|
300
|
300
|
300
|
300
|
|
| Retained Earnings |
29
|
49
|
80
|
93
|
89
|
97
|
121
|
160
|
145
|
182
|
161
|
147
|
112
|
125
|
127
|
146
|
162
|
109
|
109
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
83
|
83
|
83
|
83
|
148
|
167
|
167
|
167
|
167
|
167
|
167
|
167
|
167
|
167
|
167
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
5
|
19
|
19
|
19
|
|
| Total Equity |
122
N/A
|
142
+17%
|
173
+22%
|
186
+7%
|
372
+100%
|
380
+2%
|
404
+6%
|
515
+27%
|
568
+10%
|
649
+14%
|
628
-3%
|
614
-2%
|
579
-6%
|
595
+3%
|
595
0%
|
608
+2%
|
610
+0%
|
557
-9%
|
557
+0%
|
|
| Total Liabilities & Equity |
138
N/A
|
172
+25%
|
226
+32%
|
218
-4%
|
410
+89%
|
426
+4%
|
457
+7%
|
563
+23%
|
629
+12%
|
711
+13%
|
679
-5%
|
666
-2%
|
630
-5%
|
697
+11%
|
681
-2%
|
680
0%
|
705
+4%
|
636
-10%
|
628
-1%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
270
|
270
|
270
|
270
|
582
|
582
|
582
|
587
|
593
|
600
|
600
|
600
|
600
|
600
|
600
|
600
|
600
|
600
|
600
|
|